Latent-Y
Overview
- Complete antibody design campaigns 56 times faster than working manually, using AI that autonomously generates novel antibodies from text prompts.
- Run multiple antibody design campaigns simultaneously, with a force multiplier that lets a single researcher expand the scale of therapeutic exploration.
- Generate novel, lab-confirmed binders with single-digit nanomolar affinities, validated across several campaign types for reliable drug discovery results.
- Skip coding entirely with a complete no-coding drug design workflow fully embedded in the Latent Labs platform.
- Apply expert-level antibody design reasoning with built-in access to bioinformatics tools, biological databases, and external publications.
- Choose full end-to-end autonomy or a human-in-the-loop approach with interactive review of progress summaries and recommended next steps.
- Audit every design decision through logged AI reasoning, delivering full transparency and interpretability at each stage of protein design.
Pros & Cons
Pros
- Accelerates drug discovery
- Designs antibodies from text
- Autonomous creation of antibodies
- Runs multiple design campaigns
- Faster design campaign results
- Results lab-validated across campaigns
- Full autonomy or interactive approach
- Fully integrated into Latent Labs
- No-coding workflow for drug design
- Runs within protein design environment
- Utilizes bioinformatics tools
- Access to biological databases
- Uses external publications
- Impact on research capacity
- De novo antibody creation
- Generates lab-confirmed binders
- Design antibodies cross-species
- Design from scientific papers
- Designs from high-level objectives
- 56x faster campaign completion
- Process natural language inputs
- Parallel campaign execution
- Transparent design decisions
- 67% target-level success rate
- End-to-end lab validation
- Supports multiple design modalities
- Compresses weeks work into hours
Cons
- Complex to setup
- Limited accessibility
- Only works within Latent Labs
- Needs expert biotechnology knowledge
- Difficulty in integrating with other workflows
- Limited modality coverage
- May outsource human expertise
- Confined to specific research objectives
- Depends on underlying LLM performance
- Not tested on clinical trials
Reviews
Rate this tool
Loading reviews...
❓ Frequently Asked Questions
Latent-Y is an artificial intelligence tool developed by Latent Labs. It is specially designed to speed up the process of drug discovery with its primary focus on the design of antibodies. Alongside this, Latent-Y autonomously creates novel antibodies from text prompts, condensing weeks of work into a matter of hours.
Latent-Y uses artificial intelligence to expedite the drug discovery process. It autonomously designs new antibodies from text prompts, effectively condensing weeks of expert work into mere hours. This force multiplier operates within the same environment as protein design experts, with access to bioinformatics tools, biological databases, and external publications. A single researcher can run multiple design campaigns in parallel, transforming the scale at which a drug discovery team can explore therapeutic opportunities.
Yes, Latent-Y can independently generate novel antibodies using text prompts. These prompts detail design goals and constraints, which Latent-Y processes and then autonomously generates lab-confirmed binders. This innovative feature simplifies the design of antibodies, reducing weeks of extensive work down to just a few hours.
Text prompts play a pivotal role in the Latent-Y operation by outlining the design goals and constraints for the antibody generation process. Latent-Y processes these prompts and produces novel lab-confirmed binders, without the need for any human intervention.
Yes, the design accuracy of Latent-Y is verified with Lab-confirmed binders. After autonomously designing novel antibodies based on text prompts, Latent-Y is capable of independently confirming the binding capacity of the antibodies it produces, reaching single-digit nanomolar affinities.
Yes, one of the standout features of Latent-Y is its capacity to initiate and manage multiple design campaigns simultaneously. This allows a single researcher to operate several campaigns at once, drastically expanding the potential to explore an array of therapeutic opportunities.
Latent-Y is quite flexible and offers two distinct modes of operation. It can operate with full autonomy from end to end, or it can work in an interactive manner, involving a human-in-the-loop approach at different stages of the process.
Latent-Y gathers information from a variety of sources similar to protein design experts. It has access to bioinformatics tools, biological databases, and external publications, which provide it with a thorough and systematic framework for antibody design.
Latent-Y is fully embedded and integrated into the Latent Labs platform, providing a complete and practical lab-confirmed workflow for drug design, with no coding requirement. This seamless integration allows for a smooth and efficient workflow, advancing drug discovery capabilities.
Latent-Y expands therapeutic opportunities by allowing a single researcher to manage multiple design campaigns at the same time. This force multiplier feature offers the capacity to explore various therapeutic scenarios simultaneously, potentially leading to valuable discoveries and breakthroughs.
Yes, the results generated by Latent-Y are lab-validated. Lab-confirmed binders are produced across different campaign types, further substantiating the reliability and effectiveness of the AI tool.
Latent-Y offers a complete no-coding workflow for drug design. Users are not required to possess any coding knowledge to utilize Latent-Y, making it accessible to researchers who specialize in fields other than computer science.
Absolutely, Latent-Y operates within the same environment as protein design experts. This means it has full access to bioinformatics tools, biological databases, and external publications, enabling it to apply expert-level reasoning to quickly move from research objectives to lab-ready candidates.
Compared to traditional methods, the operational efficiency of Latent-Y is significantly higher. It notably reduces the time required for computational work in design campaigns. User studies demonstrated that design campaigns using Latent-Y were completed 56 times faster than when researchers worked by themselves.
Latent-Y showcases high operational flexibility. It is capable of running completely autonomously for end-to-end campaigns, or it can function interactively with human review at each stage. Every design decision is logged with the AI's reasoning, allowing for full transparency.
Latent-Y plays an integral role in protein design. Starting from text prompts that specify design goals and constraints, Latent-Y autonomously designs novel antibodies without requiring human intervention. This significantly reduces the overall time spent on the design process.
Latent-Y greatly impacts research capacity by enabling a single researcher to run multiple design campaigns simultaneously. This ability transforms the scale at which a drug discovery team can explore therapeutic opportunities, increasing research productivity and efficiency.
Latent-Y uses artificial intelligence to considerably accelerate the drug discovery process in healthcare. It achieves this by autonomously designing antibodies from text prompts, reducing weeks of expert work into just a few hours.
Biological databases play an instrumental role in Latent-Y's performance. By accessing these databases, along with bioinformatics tools and external publications, Latent-Y is able to operate at the same level as protein design experts.
The 'human-in-the-loop' concept in Latent-Y configuration offers a flexible collaboration model. By allowing humans to interactively review progress summaries and recommended next steps, it fosters a hybrid approach that integrates expert insight with autonomous AI activity. Every design decision is recorded with the AI's reasoning, offering interpretability at every step.
Pricing
Pricing model
No Pricing
